the future of glp 1 drugs

the future of glp 1 drugs GLP-1 in healthcare: Vital's role in enhancing metabolic treatment programs Rapid Growth of the GLP-1

Name: the future of glp 1 drugs GLP-1 in healthcare: Vital's role in enhancing metabolic treatment programs Rapid Growth of the GLP-1
Brand: coasta-de-azur.fr
SKU: 59256178095
Price: 22.77 USD
Availability: InStock
Rating: 4.0126 (10 reviews)

SKU: 59256178095

4.0

EUR22.77 EUR51.77

Pay in 4 interest-free payments of $5.69 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 13 - Aug 18

Description

Heller, O.H

$45.00 10 in stock PT-141, also known by its INN name Bremelanotide, is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (-MSH) that acts as a non-selective agonist at melanocortin receptors MC1R, MC3R, MC4R, and MC5R

With more diverse investigators, sponsors have greater support for ensuring more equitable and inclusive trials, which can lead to better retention and more complete data

The toxicity is mediated through the generation of a reactive metabolite, N-acetyl-p-benzoquinone imine (NAPQI), which depletes hepatic glutathione leading to liver injury